Back to News
Market Impact: 0.25

Salesforce vs. Palantir: Which AI Software Stock Is a Better Buy in 2026?

Source: The Motley Fool

Artificial IntelligenceCompany FundamentalsCorporate Guidance & OutlookAnalyst InsightsCapital Returns (Dividends / Buybacks)Credit & Bond MarketsLegal & Litigation

Salesforce generated $41.5B of fiscal 2026 revenue (+9.6%) and $14.4B of free cash flow, while Agentforce ARR surpassed $1.5B; however, debt rose to $39.3B by July after issuing roughly $25B to fund an accelerated share repurchase. Palantir delivered materially faster 2025 growth, with revenue up 56.2% to about $4.5B, net margin reaching 36.3%, and no debt, but trades at an 85.5x forward P/E and 71.4x sales versus Salesforce's 14.4x and 4.5x. The article favors Salesforce on valuation and cash generation despite its elevated leverage and slower fiscal 2027 growth outlook of 11%-12%, while viewing Palantir as a high-growth but premium-priced smaller portfolio position.

Analysis

The relevant CRM debate is not simply value versus growth: its leveraged buyback has converted an equity-duration software exposure into one with meaningful refinancing and rating sensitivity. At roughly $14.4B of annual FCF, the debt load remains serviceable, but incremental cash deployment is now constrained among deleveraging, acquisition integration, and ongoing repurchases. The market should discount reported margin quality where investment gains and stock compensation support earnings/cash-flow optics; the key 1-3 month catalyst is whether FY27 guidance is raised organically rather than through acquired revenue.

Agentforce monetization also creates a competitive test against MSFT rather than a clean new revenue stream. If AI agents are bundled into existing enterprise agreements, CRM may defend retention but sacrifice net revenue expansion and gross-margin upside; MSFT can absorb lower standalone AI economics because Copilot supports Azure consumption and Office/Teams lock-in. Conversely, successful deployment through the installed base could make CRM's low starting multiple durable, while data-management ownership from Informatica improves its ability to capture the AI workflow layer instead of becoming a model reseller.

PLTR's balance sheet is strategically valuable but does not immunize it from valuation risk: at an extreme sales multiple, even sustained high growth can produce poor returns if commercial deal sizes normalize or government award timing slips. The more non-obvious spillover is that PLTR's expanding enterprise footprint increases demand for NVDA compute and cloud capacity, but also exposes PLTR to customers attempting cheaper, internally built stacks around hyperscaler tooling. Consensus is likely too binary: CRM need not become an AI growth leader to rerate, while PLTR need not miss numbers for its multiple to compress.

Near term, favor CRM on relative valuation only if credit spreads remain contained and organic subscription metrics confirm that acquisition contribution is not masking deceleration. Falsify the CRM thesis on a meaningful FY27 organic-growth guide-down, weaker remaining performance obligations, or debt-funded M&A before leverage declines. Falsify the PLTR short leg if commercial growth reaccelerates with expanding deal duration and materially reduced customer concentration over the next two quarters.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.18

Ticker Sentiment

CRM0.30
MSFT-0.20
NVDA0.10
PLTR0.45

Key Decisions for Investors

  • Initiate a 3-6 month long CRM / short PLTR pair, sized beta-neutral: CRM offers a lower bar for execution while PLTR is exposed to duration-driven multiple compression. Target 15-25% relative return; stop if PLTR delivers two consecutive quarters of accelerating commercial growth with durable margin expansion, or CRM cuts organic growth expectations.
  • For CRM, wait for the next earnings release to verify organic growth, RPO/cRPO trends, and net leverage before adding outright exposure. Add only if management demonstrates that AI and data products offset acquisition-related growth dilution; avoid if incremental buybacks or M&A are debt funded.
  • Buy CRM 6-9 month call spreads rather than unhedged common if implied volatility is reasonable, using a strike structure that monetizes a modest multiple rerating rather than requiring AI-driven hypergrowth. The thesis is a rerating toward a more normal large-cap software multiple; maximum loss should be limited to premium.
  • Maintain PLTR as a tactical underweight rather than a fundamental short ahead of contract or guidance events. Set an alert for any slowdown in commercial customer additions, large-deal conversion, or government bookings; these are the likely catalysts for a rapid valuation reset, while headline AI partnerships alone are insufficient confirmation.

More News

From AllMind Research

Browse all research